In patients approaching this stage of heart failure, characterised by high NYHA class, recurrent hospitalisations and high NT-proBNP levels, remote monitoring of PAP can enable aggressive uptitration of medications to help reduce pressures. The gene discussed is NPPB; the disease is heart failure.